高血压病伴多重危险因素患者颈动脉中膜厚度及斑块负荷与胰岛素抵抗的关系
摘要
有研究表明,我国现患高血压疾病的人数超过2亿人,并且每年新增高血压病患者达1000万。高血压是许多病因相互作用并处于不断进展状态的疾病,为心脑血管病和外周血管病的重要危险因素,是心脑血管疾病死亡的最大危险因素之一。
出处
《心电与循环》
2013年第4期294-295,共2页
Journal of Electrocardiology and Circulation
基金
浙江省医院卫生一般研究计划A类(2011KYA165)
参考文献7
-
1Zhou M S,Schulman I H. Prevention of diabetes in hypertensive pa-tients:results and implications from the VAI[J].UE trial Vasc Health Risk Manag,2009,(03):361-368.
-
2Tmomas D Giles. New Definition of Hypertension proposed[J].J Clin Hypertension,2005,(05):505-512.
-
3Lastra G,Dhuper S,Johnson M S. Salt,aldosterone,andinsulin resistance:impact on the cardiovascular system[J].Nat Rev Cardiol,2010,(04):577-584.
-
4潘孝仁.糖尿病的诊断标准及分型[J].中华内科杂志,1997,36(6):427-429. 被引量:108
-
5孙斌,李来生,郑延松.内皮功能紊乱与心血管疾病研究进展[J].心血管病学进展,2003,24(4):300-302. 被引量:6
-
6Schulman I H,Zhou M S. Vascular insulin resistance:a potential 1ink between cardiovascular and metabolic diseases[J].{H}Current Hypertension Reports,2009,(08):48-55.
-
7Anfossi G,RUSSO I,Doronzo G. Contribution of insulin resis-tance to vascular dysfunction[J].{H}Archives of Physiology and Biochemistry,2009,(12):199-217.
二级参考文献18
-
1Taddei S. Virdis A ,Ghiadoni L,et al. Effects of Antihypeztensive Drugs on Endothelial Dysfunction : Clinical Implications [ J ]. Drugs, 2002,62 (2) : 265-284 .
-
2Inoue T, Hayashi M ,Tskayanagi K ,et al. Lipid-lowering therapy with fluvsstatin inhibits oxidative modification of low density lipoprotein and improves vascular endothelial function in hypercholesterolemic patients [ J ]. Atheroselerosis.2002.160(2) : 369-376.
-
3Lopez Farre A. Casado S. Heart failure, redox alterations, and endothelial dys-fun- ction[J]. Hypertension,2001,38(6) : 1400-1405.
-
4Woodman OL. Pharmacological approaches to preserving and restoring coronary endothelial function[ J]. Expert Opin Pharmacother,2001,2( 11 ) : 1765-1775.
-
5Muzykantov VR. Targeting of superoxide dismutue and catalase to vascular endothelium[J]. J Control Release,2001,71 ( 1 ) : 1-21 .
-
6Levine GN, Frei B, Koulouris SN, et al. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease [ J ]. Circulation,1996,93(6) : 1107-1113.
-
7Adams MR,McCredie R,Jessup W,et al. Oral L-arginine improves endotheli-um- dependent dilatation and reduces monocyte adhesion to endothelial cells in young men with coronary artery disease [ J ]. Atherooelerosis, 1997. 129 ( 2 ) :261-269.
-
8Ito M ,Soma M, Izumi Y, et al. Effects of long-term treatment with angiotensinconverting enzyme inhibitor on angiotensin II and prostacyclin release from mesentenc arteries in spontaneously hypertensive rats [ J ]. Prostaglandins Leukot Essent Fatty Acids,1995,53(5) : 359-363.
-
9Kurzelewski M, Czarnowska E, Beresewicz A. Endothelin in the mechanism of endothelia] injury and neutrophil adhesion in the post-ischemic guineapig heart[J]. Eur J Pharmacol,2002,434(1-2) : 95-107.
-
10Herrington DM ,Klein KP. Cardiovascular trials of estrogen replacement therapy[J]. Ann N Y Acad Sci,2001,49: 153-162.
共引文献112
-
1刘皆,吕芳,王国娟,胡国平,孙春萍,张强,司玮,马维青.2型糖尿病患者心外膜脂肪厚度、空腹C肽与周围血管病变的相关性分析[J].湖南师范大学学报(医学版),2020,17(3):132-136. 被引量:7
-
2殷波.糖尿病酮症合并肺结核患者的心理分析及护理[J].中国现代药物应用,2009,3(5):145-146. 被引量:1
-
3樊海燕,董欣宇.糖尿病合并结肠癌患者的护理[J].当代护士(下旬刊),2010,17(9):36-37. 被引量:1
-
4周嘉鹤.加味枳术汤治疗2型糖尿病性胃轻瘫40例[J].福建中医药,2004,35(3):22-23. 被引量:4
-
5马文璠.福辛普利对2型糖尿病患者尿白蛋白排泄率和肾血流动力学的影响[J].山东医药,2004,44(19):26-26.
-
6邵兰荣.地麦消渴胶囊治疗2型糖尿病疗效观察[J].河北中医,2004,26(7):544-544. 被引量:1
-
7黄晓春,温丽艳,张乐山,熊冬根.高血压、高血脂、高血糖系统防治报告[J].九江学院学报(自然科学版),2004,19(4):78-79.
-
8潘中瑛.加味温胆汤治疗糖尿病伴高脂血症35例[J].河北中医,2005,27(3):198-199. 被引量:2
-
9陈利国,马民,屈援,张春玲,苗俊英,孙兆贵,张庆祥.高血压病、2型糖尿病血瘀证与非血瘀证患者白细胞HSP70基因表达研究[J].山东中医药大学学报,2005,29(1):21-23. 被引量:7
-
10杨富志.参芪虫草合剂对早期糖尿病肾病相关指标的影响[J].中国中医药科技,2005,12(4):228-228.
-
1李杰.辛伐他汀对动脉硬化的影响[J].中华今日医学杂志,2003,3(17):16-17.
-
2张冰,任澎.阿托伐他汀对冠心病患者血脂水平及颈动脉粥样硬化斑块的影响[J].临床和实验医学杂志,2013,12(10):774-775. 被引量:21
-
3卢学超.氟伐他汀联合西洛他唑治疗糖尿病患者颈动脉内膜中层厚度疗效观察[J].临床合理用药杂志,2013,6(34):36-36.
-
4王琦武,钟继明,黄学成.颈动脉中膜厚度及踝臂指数对冠心病的预测价值[J].中国老年学杂志,2013,33(12):2747-2749. 被引量:23
-
5赵凡,区转焕,文达辉.2型糖尿病患者糖负荷后血脂紊乱与颈动脉内中膜厚度关系[J].广州医药,2006,37(2):16-19.
-
6芦海,朱栓立,乔华,董春平,张淑华.高血压伴与不伴缺血性脑卒中患者颈动脉内中膜厚度的研究[J].心肺血管病杂志,2001,20(3):149-150. 被引量:2
-
7高东玲,魏彦红.探讨糖调节受损与颈动脉中膜厚度的关系及意义[J].西部中医药,2012,25(9):120-121.
-
8许卓帆,吕敏清,岳晓军.血压晨峰与大动脉硬化程度的关系[J].实用临床医学(江西),2014,15(1):7-9. 被引量:3
-
9王晓晖,张定华,芦少敏,连琯,张东鹏.糖前康胶囊对糖耐量减低患者颈动脉中膜厚度、血流变学及血脂的影响[J].西部中医药,2011,24(12):13-16. 被引量:3
-
10陆明雪,刘红伟,吴景华.2型糖尿病合并颈动脉粥样硬化与超敏C反应蛋白及同型半胱氨酸的关系[J].中国临床研究,2015,28(10):1316-1318. 被引量:11